We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





Subtle Medical Showcases AI-Powered Imaging Workflow Solutions at RSNA 2022

By MedImaging International staff writers
Posted on 29 Nov 2022
Print article
Image: Subtle`s software solutions are trusted in over 400 sites worldwide (Photo courtesy of Subtle Medical)
Image: Subtle`s software solutions are trusted in over 400 sites worldwide (Photo courtesy of Subtle Medical)

Subtle Medical, Inc. (Menlo Park, CA, USA) is showcasing its award winning AI-powered software solutions, SubtleMR and SubtlePET, alongside a robust pipeline of new products in research and development, at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). Subtle’s solutions provide hospitals and imaging centers the flexibility to deliver faster, higher quality PET and MRI exams.

SubtleMR uses denoising and resolution enhancement to improve MRI image quality on original and accelerated protocols, while SubtlePET denoises low count PET images acquired in up to 25% of the original scan time. With faster scan times, centers can dramatically increase profitability, workflow efficiency, and patient comfort. SubtleSYNTH, currently FDA pending, uses deep learning to synthesize STIR like contrast from already acquired T1 and T2 contrasts. The first commercial release will support spine imaging with other anatomies to follow. Subtle's (AI) products (both FDA cleared and CE marked) have been commercially deployed in over 400 sites worldwide. Subtle has developed partnerships with leading pharmaceutical manufacturers, imaging equipment manufacturers, and pharmaceutical clinical trial business companies.

Subtle is also taking part in the Imaging Artificial Intelligence in Practice (IAIP) demonstration at RSNA 2022. The IAIP demo is a showcase of new AI technologies and integration standards needed to embed AI into the diagnostic radiology workflow. The interactive exhibit enables attendees to learn what is possible, identify the right questions to ask, and learn how to introduce and scale AI into their radiology practices. Using real-world clinical scenarios involving both emergent and long-term care, 19 vendors with 30 products will walk RSNA 2022 meeting attendees through the exhibit to see AI tools and health information technology standards in action. The demonstration highlights steps in the radiology workflow where AI can assist the radiologist and improve the efficiency and quality of care: from radiologist scheduling and imaging examination ordering to acquisition protocoling, image interpretation with AI clinical decision support at the point of care, reporting, and electronic health record integration.

"Subtle Medical is dedicated to investing in healthcare innovation for the benefit of all of our customers and their patients," said Ajit Shankaranarayanan, Chief Product Officer at Subtle Medical. "SubtleMR, in combination with Equium's AI-driven demand and capacity forecasting, will enable optimum resource utilization and efficiency for radiologists and administrators. We're looking forward to showcasing our partnership at this year's RSNA IAIP demo."

Related Links:
Subtle Medical, Inc.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Under Table Shield
3 Section Double Pivot Under Table Shield
New
C-Arm with FPD
Digiscan V20 / V30
New
Ultrasound Software
UltraExtend NX

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.